Inconsistencies in the association between the JAK2V617F mutation and PRV-1 over-expression among the chronic myeloproliferative diseases

被引：6

作者：

Vannucchi, AM ^{[1
]}

Guglielmelli, P ^{[1
]}

Antonioli, E ^{[1
]}

Mappa, S ^{[1
]}

Pancrazzi, A ^{[1
]}

Bogani, C ^{[1
]}

Ponziani, V ^{[1
]}

Bosi, A ^{[1
]}

机构：

[1] Univ Florence, Azienda Osped Univ Careggi, Dept Haematol, Florence, Italy

来源：

BRITISH JOURNAL OF HAEMATOLOGY | 2006年 / 132卷 / 05期

关键词：

myeloproliferative diseases; JAK2; PRV-1;

D O I：

10.1111/j.1365-2141.2005.05951.x

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

引用

页码：652 / 654

页数：4

共 8 条

[1] Clinical implications of the JAK2 V617F mutation in essential thrombocythemia [J].

Antonioli, E ;

Guglielmelli, P ;

Pancrazzi, A ;

Bogani, C ;

Verrucci, M ;

Ponziani, V ;

Longo, G ;

Bosi, A ;

Vannucchi, AM .

LEUKEMIA, 2005, 19 (10) :1847-1849

[2] Acquired mutation of the tyrosine kinase JAK2 in human myeloproliferative disorders [J].

Baxter, EJ ;

Scott, LM ;

Campbell, PJ ;

East, C ;

Fourouclas, N ;

Swanton, S ;

Vassiliou, GS ;

Bench, AJ ;

Boyd, EM ;

Curtin, N ;

Scott, MA ;

Erber, WN ;

Green, AR .

LANCET, 2005, 365 (9464) :1054-1061

[3] Pathogenesis of thrombosis in essential thrombocythemia and polycythemia vera: The role of neutrophils [J].

Falanga, A ;

Marchetti, M ;

Barbui, T ;

Smith, CW .

SEMINARS IN HEMATOLOGY, 2005, 42 (04) :239-247

[4] The Jak2V617F mutation, PRV-1 overexpression, and EEC formation define a similar cohort of MPD patients [J].

Goerttler, PS ;

Steimle, C ;

März, E ;

Johansson, PL ;

Andreasson, B ;

Griesshammer, M ;

Gisslinger, H ;

Heimpel, H ;

Pahl, HL .

BLOOD, 2005, 106 (08) :2862-2864

[5] Widespread occurrence of the JAK2 V617F mutation in chronic myeloproliferative disorders [J].

Jones, AV ;

Kreil, S ;

Zoi, K ;

Waghorn, K ;

Curtis, C ;

Zhang, LY ;

Score, J ;

Seear, R ;

Chase, AJ ;

Grand, FH ;

White, H ;

Zoi, C ;

Loukopoulos, D ;

Terpos, E ;

Vervessou, EC ;

Schultheis, B ;

Emig, M ;

Ernst, T ;

Lengfelder, E ;

Hehlmann, R ;

Hochhaus, A ;

Oscier, D ;

Silver, RT ;

Reiter, A ;

Cross, NCP .

BLOOD, 2005, 106 (06) :2162-2168

[6] Altered gene expression in myeloproliferative disorders correlates with activation of signaling by the V617F mutation of Jak2 [J].

Kralovics, R ;

Teo, SS ;

Buser, AS ;

Brutsche, M ;

Tiedt, R ;

Tichelli, A ;

Passamonti, F ;

Pietra, D ;

Cazzola, M ;

Skoda, RC .

BLOOD, 2005, 106 (10) :3374-3376

[7] Concomitant neutrophil JAK2V617F mutation screening and PRV-1 expression analysis in myeloproliferative disorders and secondary polycythaemia [J].

Tefferi, A ;

Sirhan, S ;

Lasho, TL ;

Schwager, SM ;

Li, CY ;

Dingli, D ;

Wolanskyj, AP ;

Steensma, DP ;

Mesa, R ;

Gilliland, DG .

BRITISH JOURNAL OF HAEMATOLOGY, 2005, 131 (02) :166-171

[8] PRV-1, erythroid colonies and platelet Mpl are unrelated to thrombosis in essential thrombocythaemia [J].

Vannucchi, AM ;

Grossi, A ;

Pancrazzi, A ;

Antonioli, E ;

Guglielmelli, P ;

Balestri, F ;

Biscardi, M ;

Bulgarelli, S ;

Longo, G ;

Graziano, C ;

Gugliotta, L ;

Bosi, A .

BRITISH JOURNAL OF HAEMATOLOGY, 2004, 127 (02) :214-219

← 1 →